Vaginitis Therapeutics - Pipeline Assessment and

Market Forecasts to 2019

On 30th December 2014

Summary
The industry analysis specialist, has released its new report, Vaginitis Therapeutics - Pipeline
Assessment and Market Forecasts to 2019. The report is an essential source of information
and analysis on the global Vaginitis Infection Therapeutics market. The report identifies the key
trends shaping and driving the global Vaginitis Infection Therapeutics market. The report also
provides insights on the prevalent competitive landscape and the emerging players expected to
significantly alter the market positioning of the current market leaders. Most importantly, the
report provides valuable insights on the pipeline products within the global Vaginitis Infection
Therapeutics sector. This report is built using data and information sourced from proprietary
databases, primary and secondary research and in-house analysis by GlobalDatas team of
industry experts.
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

You can buy this Report @ http://www.jsbmarketresearch.com/healthcare-medical/rvaginitis-therapeutics-pipeline-assessment-and-market-forecasts-135198

Scope
The report provides information on the key drivers and challenges of the Vaginitis Infection
Therapeutics market. Its scope includes - Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Vaginitis
Infection Therapeutics market revenues data from 2006 to 2011, forecast for eight years to
2019.
- Pipeline analysis data providing a split across the different phases, mechanisms of action being
developed and emerging trends by seven key markets. Pipeline candidates fall under major
therapeutic classes.
- Analysis of the current and future competition in the seven key countries Vaginitis Infection
Therapeutics market.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is
independently researched to provide a qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet
needs and the implications for the Vaginitis Infection Therapeutics market.
- Analysis of key recent licensing and partnership agreements in Vaginitis Infection Therapeutics
market

Reasons to buy
The report will enhance your decision making capability. It will allow you to - Develop and design your in-licensing and out-licensing strategies through a review of pipeline
products and technologies and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global
Vaginitis Infection Therapeutics market.
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

- Drive revenues by understanding the key trends, innovative products and technologies,
market segments and companies likely to impact the global Vaginitis Infection Therapeutics
market in future.
- Formulate effective sales and marketing strategies by understanding the competitive
landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective
counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments
that present maximum opportunities for consolidations, investments and strategic
partnerships.
- Whats the next big thing in the global Vaginitis Infection Therapeutics market landscape?
Identify, understand and capitalize.

Other industries we cover:

Advertising and Media

Automotive and Parts
Consumer Goods
Healthcare and Medical
Finance and Banking
Food and Beverages
Travel and Tourism
Textiles and Clothing
SWOT Analysis

Discounts on Market Research Reports till 31st December, 2014

For more inquiries, contact at +91 - 998 729 5242 /
contact@jsbmarketresearch.com
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

Table of Content
2 Vaginitis Therapeutics - Introduction
2.1 Overview
2.1.1 Vaginitis Classification
2.2 Epidemiology
2.3 Etiology
2.4 Symptoms
2.5 Diagnosis
2.6 Pathophysiology
2.7 Treatment
2.8 GlobalData Pipeline Report Guide
3 Vaginitis Therapeutics - Market Characterization
3.1 Overview
3.2 Vaginitis Therapeutics Market Size (2006-2011) - Global
3.3 Vaginitis Therapeutics Market Forecast (2011-2019) - Global
3.4 Vaginitis Therapeutics Market - The US (2006-2011)
3.5 Vaginitis Therapeutics Market Forecast - The US (2011-2019)
3.6 Vaginitis Therapeutics Market - France (2006-2011)
3.7 Vaginitis Therapeutics Market Forecast - France (2011-2019)
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

3.8 Vaginitis Therapeutics Market - Germany (2006-2011)

3.9 Vaginitis Therapeutics Market Forecast - Germany (2011-2019)
3.10 Vaginitis Therapeutics Market - Italy (2006-2011)
3.11 Vaginitis Therapeutics Market Forecast - Italy (2011-2019)
3.12 Vaginitis Therapeutics Market - Spain (2006-2011)
3.13 Vaginitis Therapeutics Market Forecast - Spain (2011-2019)
3.14 Vaginitis Therapeutics Market - The UK (2006-2011)
3.15 Vaginitis Therapeutics Market Forecast - The UK (2011-2019)
3.16 Vaginitis Therapeutics Market - Japan (2006-2011)
3.17 Vaginitis Therapeutics Market Forecast - Japan (2011-2019)
3.18 Drivers and Barriers for the Vaginitis Therapeutics Market
3.18.1 Drivers for the Vaginitis Therapeutics Market
3.18.2 Barriers for the Vaginitis Therapeutics Market
3.19 Opportunity and Unmet Need
3.20 Key Takeaway
4 Vaginitis Therapeutics - Competitive Assessment
4.1 Overview
4.1.1 Strategic Competitor Assessment
4.2 Product Profile for the Major Marketed Products in the MI Therapeutics Market
4.2.1 Anti-Fungals
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

4.2.2 Boric acid

4.3 Key Takeaway
5 Vaginitis Therapeutics - Pipeline Assessment
5.1 Overview
5.2 Strategic Pipeline Assessment
5.3 Profile for Late Stage Molecules Under Clinical Development
5.3.1 Lcr35
5.3.2 Ketoconazole and Clindamycin Combination
5.3.3 Clindamycin phosphate and butoconazole nitrate combination
5.3.4 Trimo-San gel
5.4 Vaginitis Therapeutics Market - Clinical Pipeline by Mechanism of Action
5.4.1 Vaginitis Therapeutics - Phase III Clinical Pipeline
5.4.2 Vaginitis Therapeutics - Phase II Clinical Pipeline
5.4.3 Vaginitis Therapeutics - Phase I Clinical Pipeline
5.4.4 Vaginitis Therapeutics - Preclinical Pipeline
5.5 Key Takeaway
6 Vaginitis Therapeutics - Clinical Trials Mapping
6.1 Clinical Trials by Region/Country (the US, EU5 & Japan)
6.2 Clinical Trials by Phase of Clinical Development
6.3 Clinical Trials by Trial Status
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

6.4 Clinical Trials by Sponsors

6.5 Brief Profiles of Top 10 Companies Participating in Clinical Trials
7 Vaginitis Therapeutics - Strategic Assessment
7.1 Key Events Impacting the Future Market
7.2 Future Market Competition Scenario
8 Vaginitis Therapeutics - Future Players
8.1 Introduction
8.1.1 KV Pharmaceutical Company
8.1.2 Mission Pharmacal
8.1.3 Merck & Co., Inc.
8.1.4 Starpharma Holdings limited
8.1.5 Pfizer Inc.
8.1.6 Tabular Presentation Details of Other Companies in the Pipeline
9 Vaginitis Therapeutics - Licensing and Partnership Deals
10 Vaginitis Therapeutics - Appendix
10.1 Definitions
10.2 Acronyms
10.3 Methodology
10.3.1 Coverage
10.3.2 Secondary Research
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

10.3.3 Forecasting
10.3.4 Primary Research
10.3.5 Expert Panel Validation
10.4 Contact Us
10.5 Disclaimer
10.6 Bibliography

List Of Tables
Table 1: Features of the Most Common Causes of Vaginitis
Table 2: Treatments of the Most Common Causes of Vaginitis
Table 3: Vaginitis Therapeutics Market, Global, Revenue ($m), 2006-2011
Table 4: Vaginitis Therapeutics Market, Global, Forecast ($m), 2011-2019
Table 5: Vaginitis Therapeutics Market, The US, Forecast ($m), 2006-2011
Table 6: Vaginitis Therapeutics Market, The US, Forecast ($m), 2011-2019
Table 7: Vaginitis Therapeutics Market, France, Revenue ($m), 2006-2011
Table 8: Vaginitis Therapeutics Market, France, Forecast ($m), 2011-2019
Table 9: Vaginitis Therapeutics Market, Germany, Revenue ($m), 2006-2011
Table 10: Vaginitis Therapeutics Market, Germany, Forecast ($m), 2011-2019
Table 11: Vaginitis Therapeutics Market, Italy, Revenue ($m), 2006-2011
Table 12: Vaginitis Therapeutics Market, Italy, Forecast ($m), 2011-2019
Table 13: Vaginitis Therapeutics Market, Spain, Revenue ($m), 2006-2011
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

Table 14: Vaginitis Therapeutics Market, Spain, Forecast ($m), 2011-2019

Table 15: Vaginitis Therapeutics Market, The UK, Revenue ($m), 2006-2011
Table 16: Vaginitis Therapeutics Market, The UK, Forecast ($m), 2011-2019
Table 17: Vaginitis Therapeutics Market, Japan, Revenue ($m), 2006-2011
Table 18: Vaginitis Therapeutics Market, Japan, Forecast ($m), 2011-2019
Table 19: Vaginitis Therapeutics - Phase III Clinical Pipeline, 2011
Table 20: Vaginitis Therapeutics - Phase II Clinical Pipeline, 2011
Table 21: Vaginitis Therapeutics - Phase I Clinical Pipeline, 2011
Table 22: Vaginitis Therapeutics - Preclinical Pipeline, 2011
Table 23: Vaginitis Therapeutics, Global, Clinical Trials, 2011
Table 24: Vaginitis Therapeutics, Global, Clinical Trials by Phase, 2011
Table 25: Vaginitis Therapeutics, Global, Clinical Trials by Status of Development, 2011
Table 26: Vaginitis Therapeutics, Global, Prominent Sponsors, 2011
Table 27: Vaginitis Therapeutics, Global, Top Ten Companies by Phase, 2011
Table 28: KV Pharmaceutical Company - Pipeline Products
Table 29 Merck & Co., Inc. - Pipeline Products
Table 30 Starpharma Holding Limited - Pipeline Products
Table 31: Other Companies in Pipeline, Therapeutics, 2011
Table 32: Therapeutics, Global, Deals, 2010

Email ID- contact@jsbmarketresearch.com

Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

List Of Figures
Figure 1: Diagnosis of Vaginitis
Figure 2: Vaginitis Therapeutics Market, Global, Revenue ($m), 2006-2011
Figure 3: Vaginitis Therapeutics Market, Global, Forecast ($m), 2011-2019
Figure 4: Vaginitis Therapeutics Market, The US, Revenue ($m), 2006-2011
Figure 5: Vaginitis Therapeutics Market, The US, Forecast ($m), 2011-2019
Figure 6: Vaginitis Therapeutics Market, France, Revenue ($m), 2006-2011
Figure 7: Vaginitis Therapeutics Market, France, Forecast ($m), 2011-2019
Figure 8: Vaginitis Therapeutics Market, Germany, Revenue ($m), 2006-2011
Figure 9: Vaginitis Therapeutics Market, Germany, Forecast ($m), 2011-2019
Figure 10: Vaginitis Therapeutics Market, Italy, Revenue ($m), 2006-2011
Figure 11: Vaginitis Therapeutics Market, Italy, Forecast ($m), 2011-2019
Figure 12: Vaginitis Therapeutics Market, Spain, Revenue ($m), 2006-2011
Figure 13: Vaginitis Therapeutics Market, Spain, Forecast ($m), 2011-2019
Figure 14: Vaginitis Therapeutics Market, The UK, Revenue ($m), 2006-2011
Figure 15: Vaginitis Therapeutics Market, The UK, Forecast ($m), 2011-2019
Figure 16: Vaginitis Therapeutics Market, Japan, Revenue ($m), 2006-2011
Figure 17: Vaginitis Therapeutics Market, Japan, Forecast ($m), 2011-2019
Figure 18: Opportunity and Unmet Need in the Vaginitis (BV) Therapeutics Market, 2011
Figure 19: Opportunity and Unmet Need in the Vaginitis (Vaginal Candidiasis) Therapeutics
Market, 2011
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

Figure 20: Opportunity and Unmet Need in the Vaginitis (Trichomoniasis) Therapeutics Market,
2011
Figure 21: Strategic Competitor Assessment, 2011
Figure 22: Technology Trends Analytics Frame Work, 2011
Figure 23: Technology Trends Analytics Frame Work - Description, 2011
Figure 24: Vaginitis Therapeutics Market - Clinical Pipeline by Mechanism of Action, 2011
Figure 25: Vaginitis Therapeutics Market - Clinical Pipeline by Phase of Development, 2011
Figure 26: Vaginitis Therapeutics, Global, Clinical Trials by Country, 2011
Figure 27: Vaginitis Therapeutics, Global, Clinical Trials by Phase (%), 2011
Figure 28: Vaginitis Therapeutics, Global, Clinical Trials by Status of Development (%), 2011
Figure 29: Vaginitis Therapeutics, Global, Overall Sponsors (%), 2011
Figure 30: Vaginitis Therapeutics, Global, Prominent Sponsors (%), 2011
Figure 31: Vaginitis Therapeutics, Global, Top Ten Companies by Phase, 2011
Figure 32: Vaginitis Therapeutics Market, Drivers and Barriers, 2011
Figure 33: Implications for Future Market Competition in the Vaginitis Therapeutics Market,
2011
Figure 34: Vaginitis Infection Therapeutics Market - Clinical Pipeline by Company, 2011
Figure 35: GlobalData Market Forecasting Model

Email ID- contact@jsbmarketresearch.com

Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

Report Price:
Licence Type

Price

PDF

$ 3995

Site Licence

$ 7990

Enterprise Wide Licence

$ 11985

Related Reports:
Pancreatitis Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Paroxysmal Nocturnal Hemoglobinuria (PNH) Therapeutics - Pipeline Assessment and Market
Forecasts to 2019
Aplastic Anemia Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Polycythemia Vera Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics - Pipeline Assessment and Market Forecasts
to 2019
Growth Hormone Deficiency (GHD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Athletes Foot Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Respiratory Syncytial Virus (RSV) Prophylactic - Pipeline Assessment and Market Forecasts to 2019
Clostridium difficile Infection (CDI) Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Haemophilus Influenzae Type B (Hib) Vaccine - Pipeline Assessment and Market Forecasts to 2019

Email ID- contact@jsbmarketresearch.com

Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

You can order this report by calling on +91 - 998 7295 242 or mail us
your contact details at contact@jsbmarketresearch.com

About JSB Market Research:JSB market research is a leading player in the market of research report distribution. It is onestop-shop for all information related to market research for any sector of the industry. Along
with providing in-depth analysis though reports, JSB market research also provides regular
updates of the market though newsletters. Our reports are a well-researched work of market
researchers with an extensive knowledge and a good level of market experience.

To know more on Vaginitis Therapeutics - Pipeline Assessment and Market

Forecasts to 2019

http://www.jsbmarketresearch.com/healthcare-medical/r-vaginitistherapeutics-pipeline-assessment-and-market-forecasts-135198

Email ID- contact@jsbmarketresearch.com

Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/